These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21717407)

  • 1. Selected markers of endothelial dysfunction in women with polycystic ovary syndrome.
    Foltyn W; Strzelczyk J; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Blicharz-Dorniak J; Kos-Kudła B
    Endokrynol Pol; 2011; 62(3):243-8. PubMed ID: 21717407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating soluble P-selectin in polycystic ovary syndrome.
    Yildiz BO; Bozdag G; Harmanci A; Otegen U; Boynukalin K; Vural Z; Kirazli S; Haznedaroglu IC; Yarali H
    Fertil Steril; 2010 May; 93(7):2311-5. PubMed ID: 19261277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome.
    Koiou E; Tziomalos K; Katsikis I; Dinas K; Tsourdi EA; Kandaraki EA; Delkos D; Papadakis E; Panidis D
    Hormones (Athens); 2012; 11(1):77-85. PubMed ID: 22450347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
    Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
    Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes.
    Sokup A; Góralczyk B; Góralczyk K; Rość D
    Acta Obstet Gynecol Scand; 2012 Feb; 91(2):182-8. PubMed ID: 21954994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.
    Bayram F; Kocer D; Ozsan M; Muhtaroglu S
    Gynecol Endocrinol; 2012 Jul; 28(7):497-501. PubMed ID: 22703625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
    Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin ameliorates endothelial dysfunction and insulin resistance in Tibet women with polycystic ovary syndrome.
    Yang B; Sun ZJ; Chen B; Zhang J; Zhao H; Li CW; Cao YK; Cao F
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1185-91. PubMed ID: 27049276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.
    Valkenburg O; Steegers-Theunissen RP; Smedts HP; Dallinga-Thie GM; Fauser BC; Westerveld EH; Laven JS
    J Clin Endocrinol Metab; 2008 Feb; 93(2):470-6. PubMed ID: 18056772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
    Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome.
    Kuşçu NK; Var A
    Acta Obstet Gynecol Scand; 2009; 88(5):612-7. PubMed ID: 19308750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation analysis between biochemical and biophysical markers of endothelium damage in children with diabetes type 1].
    Głowińska-Olszewska B; Urban M; Tołwińska J; Peczyńska J; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):221-7. PubMed ID: 16232360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
    Usselman CW; Yarovinsky TO; Steele FE; Leone CA; Taylor HS; Bender JR; Stachenfeld NS
    J Physiol; 2019 Jun; 597(11):2853-2865. PubMed ID: 30847930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
    Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
    Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis.
    Zhang Q; Zeng C; Fu Y; Cheng Z; Zhang J; Liu Z
    Nephrology (Carlton); 2012 May; 17(4):338-45. PubMed ID: 22295953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.